The invention relates to a compound of formula (I), where R
1
, R
2
, R
7
, m, n, and L
1
are as defined in claim
1
, and to the methods for preparing same, to the pharmaceutical compositions containing same, and to the uses thereof in the treatment of diseases associated with insulin resistance syndrome.
该发明涉及一种化合物,其
化学式为(I),其中R1、R2、R7、m、n和L1如权利要求书中定义的那样,以及制备该化合物的方法,含有该化合物的药物组合物,以及在治疗与
胰岛素抵抗综合征相关的疾病中的用途。